Alzheimer’s Research UK has funded over £21 million of pioneering research to help advance our understanding of different forms of frontotemporal dementia.
Our research is gaining new insights into the proteins that build up in the brain and how these damage nerve cells as well as taking these discoveries into drug discovery programmes to develop new treatments.
Backed by our passionate scientists and supporters, we’re challenging the way people think about dementia, and investing in research to make breakthroughs possible.
What is Primary progressive aphasia?
Information in this booklet is for anyone who wants to know more about primary progressive aphasia (PPA). This includes people living with PPA, their carers, families and friends.
Using stem cells and specialised chambers to unravel dementia
Researchers at the University of Manchester are using sophisticated chambers to monitor how toxic proteins spread in dementia and the complex relationship between brain cells and their blood supply.
Treating hearing loss in people at a high risk of dementia
Researchers at the University College London are developing a pilot trial to ensure people with hearing loss and mild cognitive dementia start and continue to use hearing aids. They will follow-up to evaluate its effectiveness in reducing the risk of dementia.
Looking into head injury and dementia
Research at Imperial College London is exploring the link between head injury and dementia
Designing treatments that stop protein clumping
Researchers at the University of Groningen are working to design drugs to stop the clumping of toxic proteins in the diseases that cause dementia.
Can we reduce the risk of dementia in the over 75’s?
Researchers at the University of Cambridge are exploring an whether an internet based intervention could encourage healthy lifestyle changes in people aged over 75, who are at a higher risk of developing dementia.
Was this information helpful?
Let us know what you think by filling out this short survey.